Zileuton
CAS 111406-87-2
Overview
Zileuton is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names Zyflo and Zyflo CR
Anant Labs manufacture and furnish high quality Zileuton impurities for global markets. Our Zileuton EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS111406-87-2
Mol. FormulaC11H12N2O2S
Mol. Weight236.296 g/mol
IUPAC1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
SMILESCC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
InChIInChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)
InChI KeyMWLSOWXNZPKENC-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
ZILEUTON111406-87-2ZyfloLeutrolZyflo CRZileutonumA-64077N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyureaABBOTT-64077
